5-103276123-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033211.4(MACIR):āc.204G>Cā(p.Glu68Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000424 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00035 ( 0 hom., cov: 32)
Exomes š: 0.00043 ( 0 hom. )
Consequence
MACIR
NM_033211.4 missense
NM_033211.4 missense
Scores
7
11
Clinical Significance
Conservation
PhyloP100: 3.55
Genes affected
MACIR (HGNC:25052): (macrophage immunometabolism regulator) This gene, MACIR (previously known as C5orf30), has been associated with rheumatoid arthritis, functioning as a negative regulator of tissue damage and modulating the activity of synovial fibroblasts and macrophages. The encoded protein is highly conserved in vertebrate genomes but has no significant similarity to any other human protein. [provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04982215).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MACIR | NM_033211.4 | c.204G>C | p.Glu68Asp | missense_variant | 3/3 | ENST00000319933.7 | NP_149988.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MACIR | ENST00000319933.7 | c.204G>C | p.Glu68Asp | missense_variant | 3/3 | 1 | NM_033211.4 | ENSP00000326110.2 | ||
MACIR | ENST00000510890.1 | c.204G>C | p.Glu68Asp | missense_variant | 3/3 | 2 | ENSP00000421270.1 | |||
MACIR | ENST00000515669.5 | c.204G>C | p.Glu68Asp | missense_variant | 3/3 | 3 | ENSP00000422836.1 |
Frequencies
GnomAD3 genomes AF: 0.000349 AC: 53AN: 152002Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
53
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000334 AC: 84AN: 251436Hom.: 0 AF XY: 0.000324 AC XY: 44AN XY: 135902
GnomAD3 exomes
AF:
AC:
84
AN:
251436
Hom.:
AF XY:
AC XY:
44
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000432 AC: 631AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.000439 AC XY: 319AN XY: 727246
GnomAD4 exome
AF:
AC:
631
AN:
1461890
Hom.:
Cov.:
32
AF XY:
AC XY:
319
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000348 AC: 53AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74376
GnomAD4 genome
AF:
AC:
53
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
29
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
38
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.204G>C (p.E68D) alteration is located in exon 3 (coding exon 1) of the C5orf30 gene. This alteration results from a G to C substitution at nucleotide position 204, causing the glutamic acid (E) at amino acid position 68 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
P;P;P
Vest4
MutPred
Loss of ubiquitination at K72 (P = 0.0656);Loss of ubiquitination at K72 (P = 0.0656);Loss of ubiquitination at K72 (P = 0.0656);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at